Article
RANKL Immunisation Inhibits Prostate Cancer Metastasis by Modulating EMT Through a RANKL-dependent Pathway
2020-10-30
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Prostate cancer (PCa) morbidity in the majority of patients is due to metastatic events, which are a clinical obstacle. Therefore, a better understanding of the mechanism underlying metastasis is imperative if we are to develop novel therapeutic strategies. Receptor activator of nuclear factor kappa-B (NF-κB) ligand (RANKL) regulates bone remodelling. RANKL was...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dc09c050-261f-5c71-a63e-2b8b32265d23
- DOI
- 10.21203/rs.3.rs-98591/v1
